Literature DB >> 12901838

Presenilin-1 interacts directly with the beta-site amyloid protein precursor cleaving enzyme (BACE1).

Sébastien S Hébert1, Valérie Bourdages, Chantal Godin, Mélissa Ferland, Madeleine Carreau, Georges Lévesque.   

Abstract

A neuropathological hallmark of Alzheimer's disease is the presence of amyloid plaques. The major constituent of these plaques, occurring largely in brain areas important for memory and cognition, is the 40-42 amyloid residues (Abeta). Abeta is derived from the amyloid protein precursor after cleavage by the recently identified beta-secretase (BACE1) and the putative gamma-secretase complex containing presenilin 1 (PS1). In an attempt to develop a functional secretase enzymatic assay in yeast we demonstrate a direct binding between BACE1 and PS1. This interaction was confirmed in vivo using coimmunoprecipitation and colocalization studies in human cultured cells. Our results show that PS1 preferably binds immature BACE1, thus possibly acting as a functional regulator of BACE1 maturation and/or activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901838     DOI: 10.1016/s0969-9961(03)00035-4

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  13 in total

1.  Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.

Authors:  Caty Casas; Nicolas Sergeant; Jean-Michel Itier; Véronique Blanchard; Oliver Wirths; Nicolien van der Kolk; Valérie Vingtdeux; Evita van de Steeg; Gwenaëlle Ret; Thierry Canton; Hervé Drobecq; Allan Clark; Bruno Bonici; André Delacourte; Jesús Benavides; Christoph Schmitz; Günter Tremp; Thomas A Bayer; Patrick Benoit; Laurent Pradier
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

2.  Cutting in on a secretase pas de deux.

Authors:  Michael S Wolfe
Journal:  Cell Res       Date:  2015-09-11       Impact factor: 25.617

Review 3.  Beta-secretase: structure, function, and evolution.

Authors:  Chitra Venugopal; Christina M Demos; K S Jagannatha Rao; Miguel A Pappolla; Kumar Sambamurti
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

4.  Regulation of amyloid-β production by the prion protein.

Authors:  Heledd H Griffiths; Isobel J Whitehouse; Nigel M Hooper
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

5.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease.

Authors:  Hisaaki Takahashi; Ivona Brasnjevic; Bart P F Rutten; Nicolien Van Der Kolk; Daniel P Perl; Constantin Bouras; Harry W M Steinbusch; Christoph Schmitz; Patrick R Hof; Dara L Dickstein
Journal:  Brain Struct Funct       Date:  2010-03-07       Impact factor: 3.270

6.  Presenilin 1 interacts with acetylcholinesterase and alters its enzymatic activity and glycosylation.

Authors:  María-Ximena Silveyra; Geneviève Evin; María-Fernanda Montenegro; Cecilio J Vidal; Salvador Martínez; Janetta G Culvenor; Javier Sáez-Valero
Journal:  Mol Cell Biol       Date:  2008-02-25       Impact factor: 4.272

7.  The fanconi anemia core complex acts as a transcriptional co-regulator in hairy enhancer of split 1 signaling.

Authors:  Cédric S Tremblay; Caroline C Huard; Feng-Fei Huang; Ouassila Habi; Valérie Bourdages; Georges Lévesque; Madeleine Carreau
Journal:  J Biol Chem       Date:  2009-03-25       Impact factor: 5.157

8.  Silencing of amyloid precursor protein expression using a new engineered delta ribozyme.

Authors:  Manel Ben Aissa; Marie-Claude April; Lucien-Junior Bergeron; Jean-Pierre Perreault; Georges Levesque
Journal:  Int J Alzheimers Dis       Date:  2012-02-12

Review 9.  Brain ischemia activates β- and γ-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer's disease.

Authors:  Ryszard Pluta; Wanda Furmaga-Jabłońska; Ryszard Maciejewski; Marzena Ułamek-Kozioł; Mirosław Jabłoński
Journal:  Mol Neurobiol       Date:  2012-10-19       Impact factor: 5.590

Review 10.  Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

Authors:  Ryszard Pluta; Mirosław Jabłoński; Marzena Ułamek-Kozioł; Janusz Kocki; Judyta Brzozowska; Sławomir Januszewski; Wanda Furmaga-Jabłońska; Anna Bogucka-Kocka; Ryszard Maciejewski; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2013-03-22       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.